Natural health product · NPN 80038016
INFLAMMATION
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed November 30, 2012; licence last revised October 13, 2020.
- Natural Product Number (NPN)
- 80038016
- Licence holder
- Distripharm Inc.
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- November 30, 2012
- Licence last revised
- October 13, 2020
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Curcuma longa | 75 mg | Rhizome; 20:1 extract; equivalent to 1500 mg dried herb |
| Stem bromelain | 150 mg | Stem(s) |
| Stem bromelain | 5,400,000 fcc pu | Stem(s) |
| Boswellia serrata | 75 mg | Resin; 70 % Acide boswellique |
| Zinc | 7.2 mg | Zinc gluconate |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- N/A
Non-medicinal ingredients
Gelatin; Magnesium Stearate; Cellulose, Microcrystalline